Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy

Pneumocystis jirovecii pneumonia is a life-threatening opportunistic infection in children receiving immunosuppressive chemotherapy. Without prophylaxis, up to 25% of pediatric oncology patients receiving chemotherapy will develop Pneumocystis jirovecii pneumonia. Trimethoprim-sulfamethoxazole is th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Quinn, Melissa, Fannin, J. T., Sciasci, Joseph, Bragg, Allison, Campbell, Patrick K., Carias, Delia, Crews, Kristine R., Gregornik, David, Jeha, Sima, Maron, Gabriela, Pauley, Jennifer L., Swanson, Hope D., Wolf, Joshua, Greene, William
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2018
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6105857/
https://ncbi.nlm.nih.gov/pubmed/29866879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00173-18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados